Yunyan Wan

498 total citations
23 papers, 376 citations indexed

About

Yunyan Wan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Yunyan Wan has authored 23 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Surgery. Recurrent topics in Yunyan Wan's work include Pleural and Pulmonary Diseases (6 papers), Occupational and environmental lung diseases (3 papers) and Trauma Management and Diagnosis (2 papers). Yunyan Wan is often cited by papers focused on Pleural and Pulmonary Diseases (6 papers), Occupational and environmental lung diseases (3 papers) and Trauma Management and Diagnosis (2 papers). Yunyan Wan collaborates with scholars based in China, United States and Canada. Yunyan Wan's co-authors include Dianjie Lin, Qinghua Liu, Xi-Li Li, Dezhi Li, Weijuan Chen, Wengang Li, Fei Yao, Wenjiao Li, Xiaochun Xia and Bin Li and has published in prestigious journals such as Hepatology, Scientific Reports and Medicine.

In The Last Decade

Yunyan Wan

21 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunyan Wan China 10 141 137 128 81 51 23 376
Feng-Che Kuan Taiwan 9 135 1.0× 113 0.8× 170 1.3× 68 0.8× 49 1.0× 11 438
Kaibo Guo China 13 121 0.9× 141 1.0× 175 1.4× 82 1.0× 91 1.8× 44 431
Phani Keerthi Surapaneni United States 9 85 0.6× 109 0.8× 107 0.8× 156 1.9× 101 2.0× 27 364
Yuming Rong China 13 105 0.7× 86 0.6× 178 1.4× 124 1.5× 81 1.6× 43 350
Lingling Li China 10 78 0.6× 105 0.8× 120 0.9× 53 0.7× 33 0.6× 29 308
Masaki Tsujie Japan 10 98 0.7× 117 0.9× 167 1.3× 84 1.0× 83 1.6× 44 349
Xiaofang Zou China 10 93 0.7× 244 1.8× 84 0.7× 120 1.5× 34 0.7× 39 415
Amparo Sánchez-Gastaldo Spain 9 164 1.2× 141 1.0× 168 1.3× 58 0.7× 22 0.4× 28 367

Countries citing papers authored by Yunyan Wan

Since Specialization
Citations

This map shows the geographic impact of Yunyan Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunyan Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunyan Wan more than expected).

Fields of papers citing papers by Yunyan Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunyan Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunyan Wan. The network helps show where Yunyan Wan may publish in the future.

Co-authorship network of co-authors of Yunyan Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Yunyan Wan. A scholar is included among the top collaborators of Yunyan Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunyan Wan. Yunyan Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yongfei, Jian Wang, Yunyan Wan, et al.. (2025). Postsurgery risk factors for bile duct stone recurrence. Current Problems in Surgery. 75. 101959–101959.
2.
Zhang, Gan, Danfeng Yu, Huan Pan, et al.. (2025). Post marketing safety surveillance of atezolizumab based on a retrospective analysis of the FDA adverse events reporting system (FAERS). Scientific Reports. 15(1). 42218–42218.
3.
4.
5.
6.
Zhang, Haoran, et al.. (2021). Application of circulating genetically abnormal cells in the diagnosis of early-stage lung cancer. Journal of Cancer Research and Clinical Oncology. 148(3). 685–695. 9 indexed citations
7.
Wan, Yunyan, et al.. (2020). <p>The lncRNA NORAD/miR-520a-3p Facilitates Malignancy in Non-Small Cell Lung Cancer via PI3k/Akt/mTOR Signaling Pathway</p>. OncoTargets and Therapy. Volume 13. 1533–1544. 37 indexed citations
8.
Zhao, Jingquan, et al.. (2020). Clinical efficacy of treatment for primary tracheal tumors by flexible bronchoscopy: Airway stenosis recanalization and quality of life. Experimental and Therapeutic Medicine. 20(3). 2099–2105. 2 indexed citations
9.
Wan, Yunyan, Qinghua Liu, Ling Zhu, et al.. (2019). Safety and complications of medical thoracoscopy in the management of pleural diseases. BMC Pulmonary Medicine. 19(1). 125–125. 36 indexed citations
10.
Liu, Qinghua, et al.. (2018). Evaluation of medical thoracoscopy for the pulmonary bullae with refractory spontaneous pneumothorax. Chinese Journal of Asthma. 38(10). 741–745. 1 indexed citations
11.
Zhou, Wuhua, Xuefeng Li, Yunyan Wan, et al.. (2018). Screening key candidate genes and pathways involved in insulinoma by microarray analysis. Medicine. 97(22). e10826–e10826. 6 indexed citations
12.
Liu, Qinghua, et al.. (2018). Erythromycin poudrage versus erythromycin slurry in the treatment of refractory spontaneous pneumothorax. Journal of Thoracic Disease. 10(2). 757–765. 1 indexed citations
13.
Li, Bin, et al.. (2016). Overexpression of OCT4 is associated with gefitinib resistance in non-small cell lung cancer. Oncotarget. 7(47). 77342–77347. 16 indexed citations
14.
Wan, Yunyan, et al.. (2014). Serum albumin as a significant prognostic factor in patients with malignant pleural mesothelioma. Tumor Biology. 35(7). 6839–6845. 23 indexed citations
15.
Wan, Yunyan, et al.. (2013). Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma. Journal of Cancer Research and Clinical Oncology. 139(12). 2117–2123. 68 indexed citations
16.
17.
Wan, Yunyan, et al.. (2013). Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats. Respiratory Research. 14(1). 56–56. 54 indexed citations
18.
Chen, Yongliang, et al.. (2012). Effects of partial portal vein arterialization on liver regeneration after hepatectomy in minipigs with obstructive jaundice.. PubMed. 125(13). 2302–5. 8 indexed citations
19.
Chen, Qiang, Wenjiao Li, Yunyan Wan, et al.. (2011). Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways. Hepatology. 55(6). 1820–1829. 58 indexed citations
20.
Wan, Yunyan, et al.. (2010). Multiple myeloma with pleural effusion as initial symptom:a report of one case and literature review. Chinese Journal of Asthma. 30(18). 1097–1099. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feng-Che Kuan Breakdown of academic impact, for papers by Kaibo Guo Breakdown of academic impact, for papers by Phani Keerthi Surapaneni Breakdown of academic impact, for papers by Yuming Rong Breakdown of academic impact, for papers by Lingling Li Breakdown of academic impact, for papers by Masaki Tsujie Breakdown of academic impact, for papers by Xiaofang Zou Breakdown of academic impact, for papers by Amparo Sánchez-Gastaldo
Rankless by CCL
2026